EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 26 aprile 2024. Database contains 4691 unique substances/entries.

Filter the list

Mostrati 2.001 - 2.200 su 4.691 risultati.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
methyl-ONN-azoxymethyl acetate; methyl azoxy methyl acetate	209-765-7	592-62-1	Carc. 1B; Repr. 1B
1,2,3-trichloropropane	202-486-1	96-18-4	Carc. 1B; Repr. 1B; Acute Tox. 4
nitrofen (ISO); 2,4-dichlorophenyl 4-nitrophenyl ether	217-406-0	1836-75-5	Carc. 1B; Repr. 1B; Acute Tox. 4
reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6 trione; reaction mass of oligomers of; 3,5-bis(3-aminomethylphenyl)1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5(1H,3H,5H)-triazine-2,4,6-trione BLENDUR I VP KU 3-4519	421-550-1	-	Carc. 1B; Repr. 1B; Skin Sens. 1
disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate); C.I. Direct Red 28	209-358-4	573-58-0	Carc. 1B; Repr. 2
disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate; C.I. Direct Black 38	217-710-3	1937-37-7	Carc. 1B; Repr. 2
tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate]; C.I. Direct Blue 6	220-012-1	2602-46-2	Carc. 1B; Repr. 2
2,3-dibromopropan-1-ol; 2,3-dibromo-1-propanol	202-480-9	96-13-9	Carc. 1B; Repr. 2; Acute Tox. 3; Acute Tox. 4
indium phosphide	244-959-5	22398-80-7	Carc. 1B; Repr. 2; STOT RE 1
α, α, α,4-tetrachlorotoluene; p-chlorobenzotrichloride	226-009-1	5216-25-1	Carc. 1B; Repr. 2; STOT RE 1; Acute Tox. 4; STOT SE 3; Skin Irrit. 2
spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate	604-636-5	148477-71-8	Carc. 1B; Repr. 2; STOT RE 2; Skin Sens. 1B
hexachlorobenzene	204-273-9	118-74-1	Carc. 1B; STOT RE 1
diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea	206-354-4	330-54-1	Carc. 1B; STOT RE 2
1,4,5,8-tetraaminoanthra; quinone; C.I. Disperse Blue 1	219-603-7	2475-45-8	Carc. 1B; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
4-o-tolylazo-o-toluidine; 4-amino-2',3-dimethylazobenzene; fast garnet GBC base; AAT; o-aminoazotoluene	202-591-2	97-56-3	Carc. 1B; Skin Sens. 1
captafol (ISO);1,2,3,6-tetrahydro-N-(1,1,2,2- tetrachloroethylthio)phthalimide	219-363-3	2425-06-1	Carc. 1B; Skin Sens. 1
chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex	-	-	Carc. 1B; Skin Sens. 1
(3-chloro-2-hydroxypropyl); trimethylammonium chloride ... %	222-048-3	3327-22-8	Carc. 2
(5-chloro-2-methoxy-4-methyl-3-pyridyl) (4,5,6-trimethoxy-o-tolyl)methanone; pyriofenone	692-456-8	688046-61-9	Carc. 2
1,5-naphthylenediamine	218-817-8	2243-62-1	Carc. 2
4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane B-TUM	418-770-5	151882-81-4	Carc. 2
4-vinylcyclohexene	202-848-9	100-40-3	Carc. 2
5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]-1H-pyrazole-4-carboxamide; 2'-[(RS)-1,3-dimethylbutyl]-5-fluoro-1,3-dimethylpyrazole-4-carboxanilide; penflufen	619-823-7	494793-67-8	Carc. 2
acetamide	200-473-5	60-35-5	Carc. 2
alkanes, C10-13, chloro; chlorinated paraffins, C10-13	287-476-5	85535-84-8	Carc. 2
antimony trioxide	215-175-0	1309-64-4	Carc. 2
benzyl violet 4B; α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonato benzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate	216-901-9	1694-09-3	Carc. 2
chlozolinate (ISO); ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate	282-714-4	84332-86-5	Carc. 2
daminozide (ISO); 4-(2,2-dimethylhydrazino)-4-oxobutanoic acid; N-dimethylaminosuccinamic acid	216-485-9	1596-84-5	Carc. 2
dichloromethane; methylene chloride	200-838-9	75-09-2	Carc. 2
Distillates (petroleum), light hydrocracked; Cracked gasoil [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approxi mately 160°C to 320°C (320 °F to 608 °F).] A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18, and boiling in the range of approximately 160°C to 320°C (320°F to 608°F).	265-078-2	64741-77-1	Carc. 2
fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate	276-696-7	72490-01-8	Carc. 2
foramsulfuron (ISO); 2-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-4-formamido-N,N-dimethylbenzamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-dimethylcarbamoyl-5-formamidophenylsulfonyl)urea	605-666-1	173159-57-4	Carc. 2
forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea	614-346-0	68157-60-8	Carc. 2
Fuel oil, No 2; Gasoil — unspecified [A distillate oil having a minimum viscosity of 32,6 SUS at 37,7°C (100°F) to a maximum of 37,9 SUS at 37,7°C (100 °F).] A distillate oil having a minimum viscosity of 32.6 SUS at 37.7°C (100°F) to a maximum of 37.9 SUS at 37.7°C (100°F).	270-671-4	68476-30-2	Carc. 2
Fuel oil, No 4; Gasoil — unspecified [A distillate oil having a minimum viscosity of 45 SUS at 37,7°C (100°F) to a maximum of 125 SUS at 37,7 °C (100 °F).] A distillate oil having a minimum viscosity of 45 SUS at 37.7°C (100°F) to a maximum of 125 SUS at 37.7°C (100°F).	270-673-5	68476-31-3	Carc. 2
Fuels, diesel, coal solvent extn., hydrocracked hydrogenated [Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200°C to 280°C (392°F to 536°F). Composed primarily of hydrogenated two-ring hydrocarbons andtheir alkylderivatives having carbon numbers predominantly in the range of C11 through C14.] Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200°C to 280°C (392°F to 536°F). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.	302-695-9	94114-59-7	Carc. 2
Fuels, diesel, No 2; Gasoil — unspecified [A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 °C (100 °F).] A distillate oil having a minimum viscosity of 32.6 SUS at 37.7°C (100°F) to a maximum of 40.1 SUS at 37.7°C (100°F).	270-676-1	68476-34-6	Carc. 2
Fuels, diesel; Gasoil — unspecified [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163°C to 357°C (325°F to 675°F).] A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163°C to 357°C (325°F to 675°F).	269-822-7	68334-30-5	Carc. 2
Fuels, jet aircraft, coal solvent extn.,hydrocracked hydro genated [Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180°C to 225°C (356°F to 473°F). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.] Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180°C to 225°C (356°F to 473°F). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.	302-694-3	94114-58-6	Carc. 2
furmecyclox (ISO); N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide	262-302-0	60568-05-0	Carc. 2
glass microfibres of representative composition [Calcium-aluminium-silicate fibres with random orientation with the following composition (% given by weight): SiO2 55,0-60,0 %, Al2O3 4,0-7,0 %, B2O3 8,0-11,0 %, ZrO2 0,0-4,0 %, Na2O 9,5-13,5 %, K2O 0,0-4,0 %, CaO 1,0-5,0 %, MgO 0,0-2,0 %, Fe2O3 < 0,2 %, ZnO 2,0-5,0 %, BaO 3,0-6,0 %, F2 < 1,0 %. Process: typically produced by flame attenuation and rotary process. (Additional individual elements may be present at low levels; the process list does not preclude innovation).]	-	-	Carc. 2
Hydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue; Cracked gasoil [A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 °C to 500 °C (680 °F to 932 °F). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 °C (212 °F).] A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360°C to 500°C (680°F to 932°F). It produces a finished oil having a viscosity of 4.5cSt at approximately 100°C (212°F).	307-662-2	97675-88-2	Carc. 2
iprodione (ISO); 3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide	253-178-9	36734-19-7	Carc. 2
iprovalicarb (ISO); isopropyl [(2S)-3-methyl-1-{[1-(4-methylphenyl)ethyl]amino}-1-oxobutan-2-yl]carbamate	604-209-3	140923-17-7	Carc. 2
kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate	604-351-6	143390-89-0	Carc. 2
lenacil (ISO); 3-cyclohexyl-6,7- dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione	218-499-0	2164-08-1	Carc. 2
mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine	432-140-7	110235-47-7	Carc. 2
methyl N-(isopropoxycarbonyl)-L-valyl-(3RS)-3-(4-chlorophenyl)-β-alaninate; valifenalate	608-192-3	283159-90-0	Carc. 2
Mineral wool, with the exception of those specified elsewhere in this Annex [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] show/hide Glass, oxide, chemicals This category encompasses the various chemical substances manufactured in the production of inorganic glasses. For purposes of this category, 'glass' is defined as an amorfous, inorganic, transparent, translucent or opaque material traditionally formed by fusion of sources of silica with a flux, such as an alkali-metal carbonate, boron oxide, etc. and a stabilizer, into a mass which is cooled to a rigid condition without crystallization in the case of transparent or liquid-phase separated glass or with controlled crystallization in the case of glass-ceramics. The category consists of the various chemical substances, other than by-products or impurities, which are formed during the production of various glasses and concurrently incorporated into a glass mixture. All glasses contain one or more of these substances, but few, if any, contain all of them. The elements listed below are principally present as components of oxide systems but some may also be present as halides or chalcogenides, in multiple oxidation states, or in more complex compounds. Trace amounts of other oxides or chemical compounds may be present. Oxides of the first seven elements listed* comprise more than 95 percent, by weight, of the glass produced. @Aluminium@Lead@Boron@Lithium@Calcium@Manganese@Magnesium@Molybdenum@Potassium@Neodymium@Silicon@Nickel@Sodium*@Niobium@Antimony@Nitrogen@Arsenic@Phosphorus@Barium@Praseodymium@Bismuth@Rubidium@Cadmium@Selenium@Carbon@Silver@Cerium@Strontium@Cesium@Sulfur@Chromium@Tellurium@Cobalt@Tin@Copper@Titanium@Germanium@Tungsten@Gold@Uranium@Holmium@Vanadium@Iron@Zinc@Lanthanum@Zirconium EC / List no: 266-046-0 \| CAS no: 65997-17-3 Glass Wool EC / List no: - \| CAS no: 308066-92-4	-	-	Carc. 2
musk ketone; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; 4'-tert-butyl-2', 6'-dimethyl-3',; 5'-dinitroacetophenone	201-328-9	81-14-1	Carc. 2
N-{2-[[1,1'-bi (cyclopropyl)]-2-yl] phenyl}-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide; sedaxane	688-331-2	874967-67-6	Carc. 2
Potassium titanium oxide(K2Ti6O13)	432-240-0	12056-51-8	Carc. 2
propazine (ISO);2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine	205-359-9	139-40-2	Carc. 2
propyzamide (ISO); 3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide	245-951-4	23950-58-5	Carc. 2
proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one	606-168-7	189278-12-4	Carc. 2
reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)	427-140-9	-	Carc. 2
simazine (ISO); 6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine	204-535-2	122-34-9	Carc. 2
tetrachloroethylene	204-825-9	127-18-4	Carc. 2
titanium dioxide [in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm]	236-675-5	13463-67-7	Carc. 2
triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6- (2,2,2-trifluoroethoxy)-1,3,5- triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoate	603-146-9	126535-15-7	Carc. 2
tris[2-chloro-1-(chloromethyl)ethyl] phosphate	237-159-2	13674-87-8	Carc. 2
dieldrin (ISO)	200-484-5	60-57-1	Carc. 2; Acute Tox. 1; Acute Tox. 3; STOT RE 1
bis(2-chloroethyl) ether	203-870-1	111-44-4	Carc. 2; Acute Tox. 2; Acute Tox. 1
pentachlorophenol	201-778-6	87-86-5	Carc. 2; Acute Tox. 2; Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
potassium pentachlorophenolate	231-911-3	7778-73-6	Carc. 2; Acute Tox. 2; Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
sodiumpentachlorophenolate	205-025-2	131-52-2	Carc. 2; Acute Tox. 2; Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
chloroacetaldehyde	203-472-8	107-20-0	Carc. 2; Acute Tox. 2; Acute Tox. 3; Skin Corr. 1B
polyhexamethylene biguanide hydrochloride; PHMB	608-723-9	32289-58-0	Carc. 2; Acute Tox. 2; Acute Tox. 4; STOT RE 1; Eye Dam. 1; Skin Sens. 1B
polyhexamethylene biguanide hydrochloride; PHMB	608-042-7	27083-27-8	Carc. 2; Acute Tox. 2; Acute Tox. 4; STOT RE 1; Eye Dam. 1; Skin Sens. 1B
2-methyl-m-phenylene diisocyanate; toluene-2,4-di-isocyanate	202-039-0	91-08-7	Carc. 2; Acute Tox. 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
4-methyl-m-phenylene diisocyanate; toluene-2,6-di-isocyanate	209-544-5	584-84-9	Carc. 2; Acute Tox. 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
m-tolylidene diisocyanate; toluene-diisocyanate	247-722-4	26471-62-5	Carc. 2; Acute Tox. 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
chlorothalonil (ISO); tetrachloroisophthalonitrile	217-588-1	1897-45-6	Carc. 2; Acute Tox. 2; STOT SE 3; Eye Dam. 1; Skin Sens. 1
5-nitro-o-toluidine	202-765-8	99-55-8	Carc. 2; Acute Tox. 3
5-nitro-o-toluidine hydrochloride	256-960-8	51085-52-0	Carc. 2; Acute Tox. 3
chlordecone (ISO); perchloropentacyclo[5,3,0,02,6,03,9,0 4,8]decan-5-one; decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one	205-601-3	143-50-0	Carc. 2; Acute Tox. 3
N,N-dimethylaniline	204-493-5	121-69-7	Carc. 2; Acute Tox. 3
bifenthrin (ISO); (2-methylbiphenyl-3-yl)methylrel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate	617-373-6	82657-04-3	Carc. 2; Acute Tox. 3; Acute Tox. 2; STOT RE 1; Skin Sens. 1B
1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex	210-168-9	608-73-1	Carc. 2; Acute Tox. 3; Acute Tox. 4
imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole	252-615-0	35554-44-0	Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Dam. 1
2,3,4-trichlorobut-1-ene	219-397-9	2431-50-7	Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
2-furaldehyde	202-627-7	98-01-1	Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
furfuryl alcohol	202-626-1	98-00-0	Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3
azamethiphos (ISO); S-[(6-chloro-2-oxooxazolo [4,5-b]pyridin-3(2H)-yl) methyl] O,O-dimethyl thiophosphate	252-626-0	35575-96-3	Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 1; Skin Sens. 1
camphechlor (ISO); toxaphene	232-283-3	8001-35-2	Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Skin Irrit. 2
α, α-dichlorotoluene; benzylidene chloride; benzal chloride	202-709-2	98-87-3	Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
captan (ISO);1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide	205-087-0	133-06-2	Carc. 2; Acute Tox. 3; Eye Dam. 1; Skin Sens. 1
p-toluidine; 4-aminotoluene	203-403-1	106-49-0	Carc. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
toluidine sulphate (1:1)	208-741-3	540-25-0	Carc. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
toluidinium chloride	208-740-8	540-23-8	Carc. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
aldrin (ISO)	206-215-8	309-00-2	Carc. 2; Acute Tox. 3; STOT RE 1
carbon tetrachloride; tetrachloromethane	200-262-8	56-23-5	Carc. 2; Acute Tox. 3; STOT RE 1
DDT (ISO); clofenotane (INN); dicophane;1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane; dichlorodiphenyltrichloroethane	200-024-3	50-29-3	Carc. 2; Acute Tox. 3; STOT RE 1
heptachlor (ISO); 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene	200-962-3	76-44-8	Carc. 2; Acute Tox. 3; STOT RE 2
heptachlor epoxide; 2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane	213-831-0	1024-57-3	Carc. 2; Acute Tox. 3; STOT RE 2
propargite (ISO); 2-(4-tert-butylphenoxy)cyclohexyl prop-2-ynyl sulphite	219-006-1	2312-35-8	Carc. 2; Acute Tox. 3; Skin Irrit. 2; Eye Dam. 1
pirimicarb (ISO); 2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamate	245-430-1	23103-98-2	Carc. 2; Acute Tox. 3; Skin Sens. 1
1,1,2-trichloroethane	201-166-9	79-00-5	Carc. 2; Acute Tox. 4
4,4'-methylenebis(2-ethylaniline); 4,4'-methylenebis(2-ethylbenzeneamine)	243-420-1	19900-65-3	Carc. 2; Acute Tox. 4
biphenyl-2-ylamine	201-990-9	90-41-5	Carc. 2; Acute Tox. 4
carbaryl (ISO); 1-naphthyl methylcarbamate	200-555-0	63-25-2	Carc. 2; Acute Tox. 4
chlordane (ISO); 1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan	200-349-0	57-74-9	Carc. 2; Acute Tox. 4
chlordimeform (ISO); N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine	228-200-5	6164-98-3	Carc. 2; Acute Tox. 4
chlordimeform hydrochloride; N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride; N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride	243-269-1	19750-95-9	Carc. 2; Acute Tox. 4
di-allate (ISO); S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate	218-961-1	2303-16-4	Carc. 2; Acute Tox. 4
monuron (ISO); 3-(4-chlorophenyl)-1,1-dimethylurea	205-766-1	150-68-5	Carc. 2; Acute Tox. 4
naphthalene	202-049-5	91-20-3	Carc. 2; Acute Tox. 4
tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one	618-075-9	87820-88-0	Carc. 2; Acute Tox. 4
methyl iodide; iodomethane	200-819-5	74-88-4	Carc. 2; Acute Tox. 4; Acute Tox. 3; STOT SE 3; Skin Irrit. 2
C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no.202-027-5);C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride	208-953-6	548-62-9	Carc. 2; Acute Tox. 4; Eye Dam. 1
4,4'-carbonimidoylbis[N, N-dimethylaniline]	207-762-5	492-80-8	Carc. 2; Acute Tox. 4; Eye Irrit. 2
difenoconazole (ISO); 1-({2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl} methyl)-1H-1,2,4-triazole; 3-chloro-4-[(2RS,4RS;2RS,4SR)-4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl] phenyl 4-chlorophenyl ether	601-613-1	119446-68-3	Carc. 2; Acute Tox. 4; Eye Irrit. 2
salts of 4,4'-carbonimidoylbis[N, N-dimethylaniline] show/hide 4,4'-bis[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo][1,1'-biphenyl]-2,2'-disulphonic acid, compound with 4,4'-carbonimidoylbis[N,N-dimethylphenylamine] (1:2) EC / List no: 277-106-0 \| CAS no: 72939-51-6 4,4'-carbonimidoylbis[N,N-dimethylaniline] acetate EC / List no: 225-801-4 \| CAS no: 5089-20-3 Decyl hydrogen sulphate, compound with 4,4'-carbonimidoylbis[N,N-dimethylaniline] (1:1) EC / List no: 281-828-1 \| CAS no: 84030-53-5 Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, mono(dodecylbenzenesulfonate) EC / List no: - \| CAS no: 82794-01-2 4,4'-carbonimidoylbis(N,N-dimethylaniline) monohydrochloride EC / List no: 219-567-2 \| CAS no: 2465-27-2 4,4'-carbonimidoylbis[N,N-dimethylanilinium] sulphate EC / List no: 282-562-9 \| CAS no: 84255-16-3 Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, monohydrochloride, (2-methoxyethoxy)acetate EC / List no: - \| CAS no: 82941-28-4 Benzenesulfonic acid, 4-dodecyl-, compd. with 4,4'-carbonimidoylbis(N,N-dimethylbenzenamine) (1:1) EC / List no: - \| CAS no: 63589-43-5 4,4'-carbonimidoylbis[N,N-dimethylaniline] nitrate EC / List no: 282-561-3 \| CAS no: 84255-15-2 Methanaminium, N-(4-(amino(4-(dimethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-methyl-, dodecyl(sulfophenoxy)benzenesulfonate (2:1) EC / List no: - \| CAS no: 63428-09-1 Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, monohydrochloride, 2-hydroxyethanesulfonate EC / List no: - \| CAS no: 86157-51-9	-	-	Carc. 2; Acute Tox. 4; Eye Irrit. 2
trisodium nitrilotriacetate	225-768-6	5064-31-3	Carc. 2; Acute Tox. 4; Eye Irrit. 2
3,5,5-trimethylcyclohex-2-enone; isophorone	201-126-0	78-59-1	Carc. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3
diethylcarbamoyl chloride	201-798-5	88-10-8	Carc. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
2,4,6-trichlorophenol	201-795-9	88-06-2	Carc. 2; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
folpet (ISO);N-(trichloromethylthio)phthalimide	205-088-6	133-07-3	Carc. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
2,2'-methylenediphenyl diisocyanate; diphenylmethane-2,2'-diisocyanate	219-799-4	2536-05-2	Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
4,4'-methylenediphenyl diisocyanate; diphenylmethane-4,4'-diisocyanate	202-966-0	101-68-8	Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
methylenediphenyl diisocyanate	247-714-0	26447-40-5	Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
o-(p-isocyanatobenzyl)phenyl isocyanate; diphenylmethane-2,4'-diisocyanate	227-534-9	5873-54-1	Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
1-vinyl-2-pyrrolidone	201-800-4	88-12-0	Carc. 2; Acute Tox. 4; STOT RE 2; STOT SE 3; Eye Dam. 1
UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine ITC 826 CONCENTRATE	422-720-8	166242-53-1	Carc. 2; Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1
fuberidazole (ISO);2-(2-furyl-)-1H-benzimidazole	223-404-0	3878-19-1	Carc. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1
transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate	405-060-5	118712-89-3	Carc. 2; Acute Tox. 4; STOT SE 1
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate	214-619-0	1166-46-7	Carc. 2; Acute Tox. 4; STOT SE 2
imiprothrin (ISO); reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate	428-790-6	72963-72-5	Carc. 2; Acute Tox. 4; STOT SE 2
tetramethrin (ISO); (1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate	231-711-6	7696-12-0	Carc. 2; Acute Tox. 4; STOT SE 2
2,6-xylidine; 2,6-dimethylaniline	201-758-7	87-62-7	Carc. 2; Acute Tox. 4; STOT SE 3; Skin Irrit. 2
reaction products of diisopropanolamine with formaldehyde (1:4)	432-440-8	220444-73-5	Carc. 2; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
tributyl phosphate	204-800-2	126-73-8	Carc. 2; Acute Tox. 4; Skin Irrit. 2
N, N-dimethylanilinium tetrakis(pentafluorophenyl)borate B1; N,N-DIMETHYLANILINUM TETRAKIS(PENTAFLUOROPHENYL)BORATE; TÉTRAKIS(PENTAFLUOROPHÉNYL)BORATE DE N,N-DIMÉTHYLANILINIUM	422-050-6	118612-00-3	Carc. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
alachlor (ISO); 2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide	240-110-8	15972-60-8	Carc. 2; Acute Tox. 4; Skin Sens. 1
etridiazole (ISO); 5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole	219-991-8	2593-15-9	Carc. 2; Acute Tox. 4; Skin Sens. 1
(4-phenylbutyl)phosphinic acid	420-450-5	86552-32-1	Carc. 2; Eye Dam. 1
1,4-dichlorobenzene; p-dichlorobenzene	203-400-5	106-46-7	Carc. 2; Eye Irrit. 2
amisulbrom (ISO); 3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide	672-776-4	348635-87-0	Carc. 2; Eye Irrit. 2
molybdenum trioxide	215-204-7	1313-27-5	Carc. 2; Eye Irrit. 2; STOT SE 3
3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate; monuron-TCA	620-358-7	140-41-0	Carc. 2; Eye Irrit. 2; Skin Irrit. 2
morpholine-4-carbonyl chloride	239-213-0	15159-40-7	Carc. 2; Eye Irrit. 2; Skin Irrit. 2
N-2-naphthylaniline; N-phenyl-2-naphthylamine	205-223-9	135-88-6	Carc. 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
leucomalachite green; N, N,N',N'-tetramethyl-4,4'-benzylidenedianiline	204-961-9	129-73-7	Carc. 2; Muta. 2
o-phenylenediamine	202-430-6	95-54-5	Carc. 2; Muta. 2; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
o-phenylenediamine dihydrochloride	210-418-7	615-28-1	Carc. 2; Muta. 2; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
Aniline	200-539-3	62-53-3	Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Skin Sens. 1
salts of aniline show/hide Anilinetrifluoroboron EC / List no: 211-539-8 \| CAS no: 660-53-7 Anilinium bromide EC / List no: 208-801-9 \| CAS no: 542-11-0 Aniline EC / List no: 200-539-3 \| CAS no: 62-53-3 Dianilinium sulphate EC / List no: 208-805-0 \| CAS no: 542-16-5 Anilinium chloride EC / List no: 205-519-8 \| CAS no: 142-04-1 Phthalic acid, compound with aniline (1:1) EC / List no: 256-856-2 \| CAS no: 50930-79-5 Anilinium acetate EC / List no: 208-802-4 \| CAS no: 542-14-3 Benzenesulfonic acid, 2(or 4)-methyl-, compd. with benzenamine (1:1) EC / List no: - \| CAS no: 70788-38-4 Anilinium p-tolylsulphonate EC / List no: 237-870-8 \| CAS no: 14034-57-2 Benzenesulfonic acid, 2,2'-dithiobis(5-methyl-, compd. with benzenamine (1:2) EC / List no: - \| CAS no: 63468-80-4 Anilinium dihydrogen phosphate EC / List no: 253-680-8 \| CAS no: 37832-42-1	-	-	Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Skin Sens. 1
1-chloro-4-nitrobenzene	202-809-6	100-00-5	Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 2
1,4-dihydroxybenzene; hydroquinone; quinol	204-617-8	123-31-9	Carc. 2; Muta. 2; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
1-(1-naphthylmethyl)quinolinium chloride CIB R634	406-220-7	65322-65-8	Carc. 2; Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
thiophanate-methyl (ISO); dimethyl (1,2-phenylenedicarbamothioyl)biscarbamate; dimethyl 4,4'-(o-phenylene) bis(3-thioallophanate)	245-740-7	23564-05-8	Carc. 2; Muta. 2; Acute Tox. 4; Skin Sens. 1
C.I. Solvent Yellow 14; 1-phenylazo-2-naphthol	212-668-2	842-07-9	Carc. 2; Muta. 2; Skin Sens. 1
methylmercuric chloride	204-064-2	115-09-3	Carc. 2; Repr. 1A; Lact.; Acute Tox. 2; STOT RE 1
lead acetate, basic	215-630-3	1335-32-6	Carc. 2; Repr. 1A; STOT RE 2
epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane	406-850-2	133855-98-8	Carc. 2; Repr. 1B
nitrobenzene	202-716-0	98-95-3	Carc. 2; Repr. 1B; Acute Tox. 3; STOT RE 1
carbetamide (ISO); (R)-1-(ethylcarbamoyl) ethyl carbanilate; (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate	240-286-6	16118-49-3	Carc. 2; Repr. 1B; Acute Tox. 4
flusilazole (ISO); bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane	617-717-5	85509-19-9	Carc. 2; Repr. 1B; Acute Tox. 4
reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole; 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole R 7623 TECHNICAL	403-250-2	-	Carc. 2; Repr. 1B; Acute Tox. 4
tris(2-chloroethyl)phosphate	204-118-5	115-96-8	Carc. 2; Repr. 1B; Acute Tox. 4
thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide	601-147-9	111988-49-9	Carc. 2; Repr. 1B; Acute Tox. 4; Acute Tox. 3; STOT SE 3
ammonium nonadecafluorodecanoate	221-470-5	3108-42-7	Carc. 2; Repr. 1B; Lact.
nonadecafluorodecanoic acid	206-400-3	335-76-2	Carc. 2; Repr. 1B; Lact.
sodium nonadecafluorodecanoate	-	3830-45-3	Carc. 2; Repr. 1B; Lact.
Ammonium salts of perfluorononan-1-oic-acid	-	4149-60-4	Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1
ammoniumpentadeca-fluorooctanoate	223-320-4	3825-26-1	Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1
perfluorononan-1-oic acid	206-801-3	375-95-1	Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1
perfluorononan-1-oic acid sodium salts	-	21049-39-8	Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1
perfluorooctanoic acid	206-397-9	335-67-1	Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1
ammonium perfluorooctanesulfonate; ammonium heptadecafluorooctanesulfonate	249-415-0	29081-56-9	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.
diethanolamine perfluorooctane sulfonate	274-460-8	70225-14-8	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.
lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate	249-644-6	29457-72-5	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.
perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid	217-179-8	1763-23-1	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.
potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate	220-527-1	2795-39-3	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.
mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt	616-995-5	8018-01-7	Carc. 2; Repr. 1B; STOT RE 2; Skin Sens. 1
(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol CP-166,221	428-010-4	82413-20-5	Carc. 2; Repr. 1B; Skin Sens. 1
vinclozolin (ISO); N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione	256-599-6	50471-44-8	Carc. 2; Repr. 1B; Skin Sens. 1
Reaction mass of 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide and 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide [≥ 78 % syn isomers ≤ 15 % anti isomers relative content]; isopyrazam	632-619-2	881685-58-1	Carc. 2; Repr. 1B; Skin Sens. 1B
chlorotoluron (ISO); 3-(3-chloro-p-tolyl)-1,1-dimethylurea	239-592-2	15545-48-9	Carc. 2; Repr. 2
N-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)- 1-methylpyrazole-4-carboxamide; pydiflumetofen	817-852-1	1228284-64-7	Carc. 2; Repr. 2
pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one	602-927-1	123312-89-0	Carc. 2; Repr. 2
tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one	604-715-4	149979-41-9	Carc. 2; Repr. 2
fentin acetate (ISO); triphenyltin acetate	212-984-0	900-95-8	Carc. 2; Repr. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
fentin hydroxide (ISO); triphenyltin hydroxide	200-990-6	76-87-9	Carc. 2; Repr. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
chloroform; trichloromethane	200-663-8	67-66-3	Carc. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 1; Eye Irrit. 2; Skin Irrit. 2
cyanamide; carbanonitril	206-992-3	420-04-2	Carc. 2; Repr. 2; Acute Tox. 3; STOT RE 2; Skin Corr. 1; Skin Sens. 1; Eye Dam. 1
dimoxystrobin (ISO); (2E)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide; (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide	604-712-8	149961-52-4	Carc. 2; Repr. 2; Acute Tox. 4
thiourea; thiocarbamide	200-543-5	62-56-6	Carc. 2; Repr. 2; Acute Tox. 4
quizalofop-P-tefuryl (ISO); (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate PANTERA; QUIZALOFOP-P-TEFURYL	414-200-4	119738-06-6	Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2
quinoclamine (ISO); 2-amino-3-chloro-1,4-naphthoquinonequinoclamine (ISO); 2-amino-3-chloro-1,4-naphthoquinone	220-529-2	2797-51-5	Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1A
molinate (ISO);S-ethyl 1-perhydroazepinecarbothioate; S-ethyl perhydroazepine-1-carbothioate	218-661-0	2212-67-1	Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1
acetochlor (ISO); 2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide	251-899-3	34256-82-1	Carc. 2; Repr. 2; Acute Tox. 4; STOT SE 3; STOT RE 2; Skin Irrit. 2; Skin Sens. 1
clorofene; chlorophene; 2-benzyl-4-chlorophenol	204-385-8	120-32-1	Carc. 2; Repr. 2; Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1; Eye Dam. 1; STOT RE 2
dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane; mirex	219-196-6	2385-85-5	Carc. 2; Repr. 2; Lact.; Acute Tox. 4
(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy} ethyl methyl carbonate; tolpyralate	701-225-3	1101132-67-5	Carc. 2; Repr. 2; STOT RE 2
benfluralin (ISO); N-butyl-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine	217-465-2	1861-40-1	Carc. 2; Repr. 2; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1
profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one	604-105-8	139001-49-3	Carc. 2; Repr. 2; Skin Sens. 1
3,3'-dimethylbiphenyl-4,4'-diyl diisocyanate	202-112-7	91-97-4	Carc. 2; Resp. Sens. 1; Skin Sens. 1A
pentachloroethane	200-925-1	76-01-7	Carc. 2; STOT RE 1

Mostrati 2.001 - 2.200 su 4.691 risultati.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 26 aprile 2024. Database contains 4691 unique substances/entries.

Footer Nav Items